Christina Takke, V-Bio Ventures 🇧🇪 | Wonder VC Woman | E17

We’re in San Sebastián 🇪🇸 with one of the top VCs in Europe, Christina Takke from V-Bio Ventures.We talk about her path to get to the top and the benefits of gender diversity for both investing and European biotech as a whole. We also talk about her investment in Argenx when it was only three employees and the venture creation had dropped since 2022. 💎 ABOUT THE SPEAKERChristina co-founded V-Bio Ventures in 2015 and is now the Managing Partner. Before this, she was a leader in the European Venture Capital world with 15 years of experience. She has been a partner at Forbion Capital Partners where she led many successful investments in biopharma and pharma companies.🔗 LINKS MENTIONEDLean years for company creation in Europe? - BioVox, Sep 2023 - https://biovox.eu/lean-years-for-company-creation-in-europe/Top 50 Investors in Biotech in 2026: Europe’s Most Active Life Sciences Funds: ⁠⁠⁠https://flot.bio/european-biotech-investors-2026/⁠⁠⁠📜 TRANSCRIPTRead the full transcript here: https://flot.bio/episode/christina-takke-v-bio-ventures/💸 DONATEWe welcome donations from individuals and businesses to support our more content creation: https://www.paypal.me/PhilipHemme⭐️ SPONSORSHIPReady to amplify your brand to influential leaders in biotech and biopharma? Contact [email protected] and unlock sponsorship opportunities in our podcasts!🫶 FOLLOW USNewsletter: http://eepurl.com/h_fnmHLinkedIn: https://www.linkedin.com/company/flot-bio/X (Twitter): https://x.com/FlotBio🙏 LIKE/FOLLOW/REVIEWDid you enjoy the episode? Please hit the like and subscribe button. Also, please let me know your thoughts in the comments below.🎙️ ABOUT FLOT.BIOFlot.Bio is a show to watch the best Europeans in biotech to help you grow. Hosted by Philip Hemme. 15k monthly views. Free.⏰ TIMESTAMPS[00:00:00] Intro[00:02:03] Top VC woman in biotech[00:08:36] European background[00:13:49] Investing in Argenx at the start[00:20:26] V-Bio story[00:25:09] Tech transfer[00:35:44] Company creation drop[00:42:39] Thanks for listening